The Center for Infection and Immunity of Lille (CIIL) and the Institut Pasteur de Lille are strongly represented at the 19th International Congress of Immunology in Vienna

Nathalie Mielcarek shared the latest breakthroughs on the nasal vaccine BPZE1.

Eik Hoffmann presented the compound testing platform for anti-tuberculosis drugs developed within the ERA4TB program.

Meanwhile, Joan Fine, Ines Leleu, Valentin Sencio, and Arnaud Machelart are showcasing their work in dynamic and inspiring poster sessions.